Skip to main content
Equibles

Point72 Asset Management, L.P.

Position in NVCR — NovoCure Ltd

CIK 1603466 STAMFORD, CT
Back to NVCR Full portfolio

Position in NVCR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$12,167,268
-$2,671,893 QoQ
Shares Held
803,120
-41.0% QoQ
Ownership
0.690%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#29
of 217 holders
Holding Since
Dec 2022
10 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in NVCR Over Time

Shares Held

Position Value (USD)

Derivatives in NVCR

reported options exposure · as of Jun 30, 2023
CallValue
$0
CallShares
0
PutValue
$622,500
PutShares
15,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $894,667,456 across 48 Medical Devices names. NVCR ranks #14 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EW
Edwards Lifesciences Corp
 1,774,120 $160,486,895
2 ABT
Abbott Laboratories
 1,551,929 $140,822,037
3 SYK
Stryker Corp
 430,094 $135,410,794
4 ZBH
Zimmer Biomet Holdings, Inc.
 879,851 $75,746,372
5 GEHC
GE HealthCare Technologies Inc.
 1,165,973 $74,633,931
6 TXG
10x Genomics, Inc.
 1,852,776 $71,035,431
7 BBNX
Beta Bionics, Inc.
 2,254,683 $35,330,882
8 IRTC
iRhythm Holdings, Inc.
 273,162 $32,492,619

All Filings in NVCR

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,167,268 803,120
2026-03-31 $14,839,161 1,361,391
2025-12-31 $11,643,413 900,496
2025-09-30 $1,506,472 116,600
2025-06-30 $8,366,000 470,000
2024-03-31 $509,538 32,600
2023-12-31 $5,500,212 368,400
2023-09-30 $186,435 11,544
2023-06-30 $1,030,569 24,833
2023-06-30 $622,500 15,000
2022-12-31 $11,369,250 155,000